Jason Boer

1.5k total citations
12 papers, 1.0k citations indexed

About

Jason Boer is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Jason Boer has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in Jason Boer's work include Pharmacogenetics and Drug Metabolism (4 papers), Cancer Mechanisms and Therapy (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Jason Boer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Cancer Mechanisms and Therapy (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Jason Boer collaborates with scholars based in United States, Netherlands and Finland. Jason Boer's co-authors include Kirk R. Henne, Sharon Diamond, Abdul Mutlib, Deepak Dalvie, Iain Gardner, Yasuhiro Nakai, John P. O’Donnell, R. Scott Obach, Shawn Harriman and Christopher L. Shaffer and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Experimental Cell Research.

In The Last Decade

Jason Boer

12 papers receiving 966 citations

Peers

Jason Boer

PHARM

ONCOL

CTM

Ping Kang United States

Benny Amore United States

Yang Sai China

Martin C. Dyroff United States

Satoru Asahi Japan

Frank Bohnenstengel Germany

Haoliang Yuan China

Ursula Müller‐Vieira Germany

Michael Zientek United States

Ping Kang United States

Jason Boer

367 ×0.9

447 ×1.5

PHARM

218 ×1.2

208 ×1.2

ONCOL

142 ×0.9

CTM

Citations per year, relative to Jason Boer Jason Boer (= 1×) peers Ping Kang

Countries citing papers authored by Jason Boer

Since Specialization

Citations

This map shows the geographic impact of Jason Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Boer more than expected).

Fields of papers citing papers by Jason Boer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Boer. The network helps show where Jason Boer may publish in the future.

Co-authorship network of co-authors of Jason Boer

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Boer. A scholar is included among the top collaborators of Jason Boer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Boer. Jason Boer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Li, Wenkui, Gordon J. Dear, Jason Boer, et al.. (2023). Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group. Clinical Pharmacology & Therapeutics. 115(5). 939–953. 1 indexed citations

Wrigley, Stephen K., et al.. (2020). Biotransformation: Impact and Application of Metabolism in Drug Discovery. ACS Medicinal Chemistry Letters. 11(11). 2087–2107. 70 indexed citations

Zhang, Qiang, Yan Zhang, Jason Boer, et al.. (2017). In Vitro Interactions of Epacadostat and its Major Metabolites with Human Efflux and Uptake Transporters: Implications for Pharmacokinetics and Drug Interactions. Drug Metabolism and Disposition. 45(6). 612–623. 12 indexed citations

Koblish, Holly K., Niu Shin, Leslie Hall, et al.. (2015). Abstract 5416: Activity of the pan-PIM kinase inhibitor INCB053914 in models of acute myelogenous leukemia. Cancer Research. 75(15_Supplement). 5416–5416. 2 indexed citations

Zhang, Qiang, Yan Zhang, Sharon Diamond, et al.. (2014). The Janus Kinase 2 Inhibitor Fedratinib Inhibits Thiamine Uptake: A Putative Mechanism for the Onset of Wernicke’s Encephalopathy. Drug Metabolism and Disposition. 42(10). 1656–1662. 85 indexed citations

Liu, Xiangdong, Qian Wang, Gengjie Yang, et al.. (2011). A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3. Clinical Cancer Research. 17(22). 7127–7138. 190 indexed citations

Diamond, Sharon, Jason Boer, Thomas Maduskuie, et al.. (2010). Species-Specific Metabolism of SGX523 by Aldehyde Oxidase and the Toxicological Implications. Drug Metabolism and Disposition. 38(8). 1277–1285. 106 indexed citations

Walker, Daniel P., Michael P. Zawistoski, Jiancheng Li, et al.. (2009). Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity. Bioorganic & Medicinal Chemistry Letters. 19(12). 3253–3258. 75 indexed citations

Fisher, Michael B., Kirk R. Henne, & Jason Boer. (2006). The complexities inherent in attempts to decrease drug clearance by blocking sites of CYP-mediated metabolism.. PubMed. 9(1). 101–9. 15 indexed citations

10.

Kalgutkar, Amit S., Iain Gardner, R. Scott Obach, et al.. (2005). A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups. Current Drug Metabolism. 6(3). 161–225. 435 indexed citations

11.

Royen, Eric A. van, Jason Boer, J. M. Wilmink, C. S. P. Jenkins, & Jan W. ten Cate. (1979). Acquired Factor XII Deficiency in a Patient with Nephrotic Syndrome. Acta Medica Scandinavica. 205(1-6). 535–539. 5 indexed citations

12.

Roos, Dirk, et al.. (1972). Dose-response of lymphocyte carbohydrate metabolism to phytohaemagglutinin. Experimental Cell Research. 75(1). 185–190. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact